Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2026-05-12 @ 8:21 PM
Study NCT ID:
NCT02717156
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-05
First Post:
2016-03-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors
Sponsor:
Organization: